ArticleHealth affairs (Project Hope)2012

In a survey, marked inconsistency in how oncologists judged value of high-cost cancer drugs in relation to gains in survival.

Peter A Ubel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.